Transasia Bio-Medicals is an Indian in-vitro diagnostics and medical technology company focused on laboratory diagnostic systems, reagents and related healthcare technologies. The company has developed a broad portfolio covering clinical chemistry, immunology, hematology, critical care, diabetes management, hemostasis, urinalysis, molecular diagnostics, blood banking and laboratory information systems.

The company operates closely with the Erba diagnostic brand and has built a significant presence in India’s laboratory diagnostics market. Its portfolio includes instruments ranging from compact systems for smaller laboratories to automated analysers designed for higher-volume diagnostic facilities.

Transasia’s current website identifies its major diagnostic categories as clinical chemistry, critical care, blood banking, diabetes management, hematology, hemostasis, immunology, urinalysis, molecular diagnostics, LIMS and blood-collection tubes.

About Transasia Bio-Medicals

Transasia Bio-Medicals has been involved in in-vitro diagnostics for approximately four decades. Its mission has centred on providing diagnostic technologies that combine laboratory performance with affordability and accessibility.

The company has expanded its diagnostic capabilities through manufacturing, research and international partnerships.

Its broader Erba diagnostic network has included operations and R&D activities in several countries, with technologies serving laboratories in emerging as well as developed markets. Transasia has previously stated that its group serves customers in more than 100 countries.

The company’s India headquarters are located in Mumbai, Maharashtra.

What Does Transasia Bio-Medicals Manufacture?

Transasia’s laboratory portfolio covers a wide range of diagnostic technologies.

Major categories include:

• Clinical chemistry analysers
• Clinical chemistry reagents
• Immunoassay systems
• ELISA systems
• Chemiluminescence immunoassay
• Hematology analysers
• ESR analysers
• Critical-care analysers
• Blood-gas and electrolyte testing
• Diabetes and HbA1c testing
• Coagulation systems
• Urinalysis systems
• Molecular diagnostics
• Blood-bank equipment
• Blood-collection tubes
• Laboratory information systems
• Diagnostic reagents
• Calibrators and quality-control materials

This broad portfolio allows the company to supply multiple diagnostic departments within a laboratory.

Clinical Chemistry: A Major Business Area

Clinical chemistry is one of the most established areas of Transasia’s diagnostic business.

Clinical chemistry analysers measure different biochemical substances in blood, serum, plasma and other samples.

These tests are commonly used to evaluate:

• Kidney function
• Liver function
• Blood glucose
• Lipid levels
• Electrolytes
• Proteins
• Enzymes
• Minerals
• Metabolic conditions

Transasia offers both semi-automated and fully automated clinical chemistry systems. Its official portfolio states that these systems are designed and manufactured in India and support applications ranging from routine chemistry to electrolytes and specialised testing.

Erba Chem 5X

The Erba Chem 5X is a semi-automated clinical chemistry analyser intended for routine chemistry, electrolytes and immunoturbidimetric assays.

The system provides multiple analytical modes, multi-point calibration and USB connectivity for computers and printers.

Transasia specifies that the system can store up to 5,000 patient results and supports a range of routine and specialised chemistry applications.

Tests associated with its reagent portfolio include parameters such as:

• Glucose
• Creatinine
• Urea
• Cholesterol
• Bilirubin
• Calcium
• Albumin
• Total protein
• Uric acid
• Chloride
• Lipase
• Phosphorus

It can also support immunoturbidimetric assays such as ASO and related testing.

EM 360 Fully Automated Chemistry Analyser

The EM 360 is a fully automated clinical chemistry analyser designed for higher laboratory workloads.

According to Transasia’s product information, the system provides a throughput of up to 360 tests per hour for photometric testing, with an optional ISE module capable of up to 600 tests per hour for specified electrolytes.

The EM 360 supports a wide test menu covering:

• Glucose
• Cholesterol
• Triglycerides
• Albumin
• Total protein
• Uric acid
• Bilirubin
• Liver enzymes
• Creatinine
• Urea
• CRP
• ASO
• HbA1c
• Ferritin
• Iron
• Magnesium
• Ammonia
• Electrolytes

The analyser also supports barcode-based sample/reagent identification as an optional feature, onboard reagent cooling and laboratory quality-control functions.

Clinical Chemistry Reagents

Diagnostic analysers require compatible reagents, calibrators and quality-control materials.

Transasia’s clinical chemistry reagent portfolio includes:

• Routine chemistry reagents
• System packs
• Immunoturbidimetric reagents
• Calibrators
• Controls
• Consumables

The company states that its chemistry reagents are available in powder and liquid-stable formats and include a broad menu of routine clinical chemistry parameters.

This integrated instrument-and-reagent model can help laboratories maintain consistency between testing systems and consumables.

Immunoassay and Immunology

Immunodiagnostics is another important part of Transasia’s portfolio.

Immunoassays use specific antigen-antibody interactions to detect or quantify substances in biological samples.

Depending on the assay, immunodiagnostic systems can be used for:

• Hormone testing
• Infectious-disease testing
• Fertility testing
• Thyroid testing
• Tumour markers
• Cardiac markers
• Autoimmune testing
• Other specialised laboratory investigations

Transasia’s current portfolio includes immunology instruments and reagents as a separate diagnostic category.

ELISA Technology

ELISA, or enzyme-linked immunosorbent assay, is a widely used immunological laboratory technique.

Transasia’s Erba portfolio includes ELISA processors and supporting equipment.

The company’s current product information features systems such as:

• Erba LisaScan EM
• Erba LisaWash JI
• Erba ELAN 30S
• Erba ELAN systems

The Erba ELAN 30S is described as a compact automated microplate system for ELISA and other microplate-based assays.

Chemiluminescence Immunoassay

Chemiluminescence technology is widely used in modern automated immunoassay laboratories because it can provide sensitive detection across a broad range of tests.

Transasia’s current portfolio includes the VERTEX IA, described by the company as a fully automated chemiluminescence immunoassay analyser.

The system is designed around:

• Automated workflow
• High-throughput testing
• Integrated operation
• High sensitivity
• Specificity
• Compact laboratory configuration

Chemiluminescence immunoassay platforms can support testing areas such as hormones, infectious diseases, tumour markers and other clinical immunoassays, depending on the validated assay menu.

Hematology Analysers

Hematology analysers examine blood cells and generate parameters used in routine blood testing.

Transasia offers hematology systems in several configurations, including:

• 3-part differential analysers
• 5-part differential analysers
• 6-part differential analysers

The company states that its hematology systems are configured for laboratories with different workload requirements.

Examples in the current portfolio include:

• H 360
• H 560
• Elite 580
• H 7100

The H 560 is a 5-part differential hematology analyser, while the H 7100 is presented as an advanced hematology system supporting CBC, differential and reticulocyte analysis.

ESR Testing

Erythrocyte sedimentation rate, or ESR, is a commonly used laboratory test associated with inflammation and certain disease-monitoring applications.

Transasia offers automated ESR systems and related reagents.

Its portfolio includes systems such as:

• Cube 30
• VES MATIC 5
• Lisa 3
• Lisa M

The company also provides ESR reagents, controls and calibrators for its hematology-related systems.

Diabetes Diagnostics

Diabetes testing is another important laboratory segment.

Transasia’s portfolio includes technologies for HbA1c and other diabetes-related testing.

HbA1c provides an estimate of average blood-glucose exposure over a period of time and is widely used in diabetes diagnosis and monitoring.

The company’s product portfolio includes the VERTEX Hb, an automated HbA1c testing system.

Transasia also supplies HbA1c reagents, controls and calibrators for compatible systems.

Critical-Care Diagnostics

Critical-care diagnostics provide rapid information that can assist clinicians in treating seriously ill patients.

Transasia’s current diagnostic categories include critical-care instruments and reagents.

The portfolio includes technologies associated with measurements such as:

• Blood gases
• Electrolytes
• Acid-base status
• Related critical-care parameters

The EC 90 is one of the products featured in Transasia’s diagnostic portfolio and uses biosensor-based technology for critical-care testing.

These systems can be particularly relevant to:

• Intensive-care units
• Emergency departments
• Operation theatres
• Critical-care laboratories
• Neonatal care

Coagulation and Hemostasis Testing

Coagulation testing evaluates how blood clots.

These tests can be important before surgery, during anticoagulant therapy and when investigating bleeding or clotting disorders.

Transasia’s portfolio includes coagulation instruments, reagents and quality-control materials.

Its product portfolio has included systems such as the ECL 105, a coagulation analyser designed for multiple assay applications.

Urinalysis

Urine analysis is another routine laboratory diagnostic area.

Automated urinalysis can reduce manual work and standardise the reading of urine-test strips.

Transasia’s portfolio includes the Laura family of urine analysers.

The Laura platform is designed to automate strip identification, calibration and sample-related analysis.

Urinalysis can provide information relevant to:

• Kidney disorders
• Urinary-tract conditions
• Diabetes
• Infection
• Metabolic abnormalities

Molecular Diagnostics

Molecular diagnostics uses DNA or RNA-based techniques to detect specific genetic or infectious targets.

Transasia has expanded its portfolio into molecular testing through its wider Erba diagnostic group.

The company has previously highlighted molecular diagnostic research and technologies for applications including HIV, tuberculosis and cancer-related testing.

The broader Erba group has also developed proprietary molecular-testing technologies through Erba Molecular.

Blood Banking and Transfusion Diagnostics

Blood banking requires specialised equipment and testing systems to help ensure blood and blood components are appropriately screened and managed.

Transasia lists blood banking as one of its current diagnostic categories.

Its broader product portfolio also includes blood-collection tubes and related laboratory products.

Blood Collection Tubes

Accurate sample collection is an important part of laboratory diagnostics.

Poor sample collection or improper handling can affect test quality even when the analyser itself is functioning correctly.

Transasia includes blood-collection tubes within its current product categories.

These products support the pre-analytical stage of laboratory testing.

Laboratory Information Management

Modern laboratories generate large amounts of patient and analytical data.

Laboratory information management systems can help laboratories organise:

• Patient records
• Sample identification
• Test orders
• Results
• Quality-control data
• Laboratory workflows
• Reports

Transasia lists LIMS as one of its current diagnostic technology categories.

Integration between analysers and laboratory software can reduce manual data entry and improve workflow efficiency.

Quality Control and Calibration

Laboratory accuracy depends not only on analysers and reagents but also on calibration and quality-control processes.

Transasia’s clinical chemistry portfolio includes dedicated calibrators and controls.

Its EMQAS programme is described by the company as a quality-assurance programme designed to support inter-laboratory, method and instrument-specific comparison of analytical performance.

Quality-control systems are particularly important in laboratories processing large numbers of patient samples.

Manufacturing and Research

Transasia has developed manufacturing and research capabilities around diagnostic technologies.

The company has previously described R&D facilities and teams working across India, Europe and other international locations.

Its strategy has included developing diagnostic systems that can be adapted to the requirements of emerging markets while maintaining modern laboratory functionality.

This approach is particularly relevant in India, where diagnostic laboratories range from small independent centres to large hospital-based laboratories and high-volume reference laboratories.

Erba Diagnostics and Transasia

The Erba brand is closely connected with Transasia’s diagnostic portfolio.

Transasia’s Indian website presents Erba-branded analysers and reagents across clinical chemistry, hematology, immunology and other diagnostic categories.

The broader Transasia-Erba group has international operations and R&D capabilities, allowing the company to develop products for multiple geographical markets.

This combination of local manufacturing and international diagnostic technology is one of the distinctive aspects of the company’s business model.

International Presence

Transasia’s diagnostic technologies are not limited to the Indian market.

The company has previously stated that its broader group serves customers in more than 100 countries and has diagnostic operations across multiple international locations.

Its diagnostic systems have been used in markets including:

• India
• Bangladesh
• Philippines
• Indonesia
• Vietnam
• Czech Republic
• Other emerging and international markets

The company has specifically highlighted acceptance of its clinical chemistry, hematology and immunology analysers in several of these countries.

Transasia Bio-Medicals in India

India is the company’s core market and an important centre for its operations.

Its India headquarters are located at:

8 Chandivali Studio Road, Andheri East, Powai, Mumbai, Maharashtra 400072.

The company provides customer and service support for its diagnostic products through its Indian network.

Because diagnostic analysers depend on regular reagent supply, calibration, preventive maintenance and technical support, an established service network is an important component of laboratory-equipment operations.

Why Transasia Is Important in the Indian Diagnostics Industry

One of Transasia’s major strengths is the breadth of its laboratory portfolio.

A diagnostic laboratory may require several different types of equipment:

Biochemistry:
Clinical chemistry analysers and reagents.

Hematology:
CBC and differential analysers.

Immunology:
ELISA and automated immunoassay platforms.

Diabetes:
HbA1c testing.

Critical care:
Rapid blood-gas and electrolyte testing.

Coagulation:
Clotting and hemostasis analysis.

Urinalysis:
Automated urine testing.

Molecular diagnostics:
DNA/RNA-based testing.

Laboratory IT:
LIMS and data-management technologies.

Transasia’s ability to participate in these different laboratory departments makes it a broad diagnostic-solutions provider rather than a company focused on only one type of analyser.

Key Transasia Products at a Glance

Diagnostic Area Examples Clinical Chemistry Erba Chem 5X, EM 360 Hematology H 360, H 560, Elite 580, H 7100 Immunology LisaScan EM, ELAN 30S Chemiluminescence VERTEX IA HbA1c VERTEX Hb Urinalysis Laura ESR Cube 30, VES MATIC 5, Lisa 3 Critical Care EC 90 Coagulation ECL 105 ELISA ELAN systems, LisaScan/LisaWash Molecular Diagnostics Erba Molecular portfolio Laboratory IT LIMS Reagents Chemistry, hematology, immunology and other diagnostic reagents

The exact availability of products and assay menus can vary by market and regulatory approval.

Frequently Asked Questions

What is Transasia Bio-Medicals?

Transasia Bio-Medicals is an Indian in-vitro diagnostics company providing laboratory instruments, reagents and diagnostic technologies across multiple clinical-testing areas.

What does Transasia Bio-Medicals manufacture?

Its portfolio includes clinical chemistry analysers, hematology systems, immunoassay equipment, critical-care analysers, HbA1c systems, coagulation analysers, urinalysis systems, molecular diagnostics, blood-banking technologies and laboratory software.

What is Erba in relation to Transasia?

Erba is the diagnostic brand closely associated with Transasia’s laboratory products. Erba-branded analysers and reagents form a major part of the company’s diagnostic portfolio in India and international markets.

Does Transasia manufacture clinical chemistry analysers?

Yes. Transasia offers both semi-automated and fully automated clinical chemistry systems. Examples include the Erba Chem 5X and EM 360.

What is the EM 360?

The EM 360 is a fully automated clinical chemistry analyser designed for laboratory workloads. Transasia specifies a photometric throughput of up to 360 tests per hour and an optional ISE configuration for electrolyte testing.

Does Transasia manufacture hematology analysers?

Yes. Its hematology portfolio includes 3-part, 5-part and 6-part differential systems, including products such as H 360, H 560 and Elite 580.

Does Transasia make immunoassay systems?

Yes. The company offers ELISA and immunology systems and also has the VERTEX IA automated chemiluminescence immunoassay analyser in its current portfolio.

Does Transasia offer HbA1c testing equipment?

Yes. Its portfolio includes the VERTEX Hb automated HbA1c testing system, along with related reagents and controls.

Does Transasia provide laboratory reagents?

Yes. Its reagent portfolio covers clinical chemistry, hematology, immunology and other diagnostic categories, including controls and calibrators.

Where is Transasia Bio-Medicals headquartered?

The company’s India headquarters are in Mumbai, Maharashtra.

Which laboratories can use Transasia equipment?

Depending on the specific product, Transasia systems can be used in small diagnostic laboratories, medium-sized laboratories, hospital laboratories, high-volume diagnostic centres and specialised testing facilities.

Conclusion

Transasia Bio-Medicals has established a broad position in India’s in-vitro diagnostics industry by combining laboratory instruments, reagents, quality-control products and diagnostic technologies.

Its portfolio extends from clinical chemistry and hematology to immunoassay, chemiluminescence, HbA1c, critical-care testing, coagulation, urinalysis and molecular diagnostics.

Products such as the Erba Chem 5X and EM 360 demonstrate the company’s presence in clinical chemistry, while its hematology, immunology and molecular-diagnostics portfolios allow it to address a much wider range of laboratory requirements.

The company’s combination of Indian manufacturing, diagnostic R&D, the Erba product ecosystem and international distribution has helped it build a significant presence in laboratory diagnostics in India and overseas.

For hospitals, pathology laboratories and diagnostic centres looking for integrated laboratory technology across multiple testing departments, Transasia Bio-Medicals represents one of India’s notable diagnostic-equipment companies.